bioRxiv · 10.1101/2024.12.18.629278
Contribution of front-line, standard of care drugs to bactericidal responses, resistance emergence, and cure in murine models of easy- or hard-to-treat tuberculosis disease
Abstract
By assessing the standard of care regimen for tuberculosis (TB) in BALB/c and C3HeB/FeJ mice, we demonstrate that rifampin, with or without pyrazinamide, is essential to effective bactericidal response and resistance suppression. Potency measurements in an in vitro lipid-rich model and rabbit caseum assay recapitulate the significance of rifampin as a sterilizing agent. These outcomes align with clinical performance, thus emphasizing the value of in vitro predictive tools and murine TB models with human-like pathology.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Peroutka-Bigus, N., Brooks, E. J., Ramey, M. E., D'Erasmo, H., Ernest, J. P., Bauman, A. A., Woolhiser, L. K., Savic, R. M., Lenaerts, A. J., Aldridge, B., Sarathy, J. P., Robertson, G. T.. 2024-12-22. Contribution of front-line, standard of care drugs to bactericidal responses, resistance emergence, and cure in murine models of easy- or hard-to-treat tuberculosis disease. https://doi.org/10.1101/2024.12.18.629278
Cite the original work for its findings. Save a collection to share your selection of sources.